Hero Technologies Stock Price, News & Analysis
Company Description
Hero Technologies (OTC Link: HENC) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $55.3K.
HENC stock has declined 100.0% over the past year. Shares last traded at $0.0000.
On a trailing twelve-month basis, Hero Technologies reported revenue of $0 with net income of -$542K.
This page provides a comprehensive overview of HENC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Hero Technologies (HENC) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $55.3K, HENC is classified as a micro-cap stock with approximately 552.7M shares outstanding.
Latest News
Hero Technologies has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 2 with negative movement. View all HENC news →
SEC Filings
Financial Highlights
net income was -$542K. The company generated -$185K in operating cash flow. With a current ratio of 0.05, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
HENC Company Profile & Sector Positioning
Hero Technologies (HENC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing HENC often look at related companies in the same sector, including Owc Pharmaceutical Resh Corp (OWCP), Cannonau Corp (CNNC), Western Sierra R (WSRC), Radiko Holdings (GEATF), and Emergent Health (EMGE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HENC's relative position within its industry.